Please ensure Javascript is enabled for purposes of website accessibility

Israeli Tanks Close in on Gaza City, Trump to Chair Meeting

2 hours ago

Wall Street Opens Muted in Countdown to Nvidia Earnings

2 hours ago

Fresno Leaders Voice ‘Full Support’ for Pismo’s Restaurant Manager in ICE Custody

19 hours ago

Poll: Katie Porter Holds Early Edge in California Governor’s Race

21 hours ago

Just 38% of Americans Support Trump’s Use of Troops to Police DC, Reuters/Ipsos Poll Finds

22 hours ago

Families Leave Gaza City After Night of Bombardment, Israelis Protest

24 hours ago

California Farming Couple Seeks $300 Million for Aspen Estate

1 day ago

Trump Administration Cannot Sue Maryland Federal Judges Over Immigration Order, Judge Rules

1 day ago

California Republicans Sue to Block Congressional Redistricting Plan

2 days ago

Trump To Sign Executive Order Directing AG To Prosecute Flag Desecration

2 days ago
Pfizer Seeking Emergency Use of Its COVID-19 Vaccine
gvw_ap_news
By Associated Press
Published 5 years ago on
November 20, 2020

Share

Pfizer said Friday it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic — but not until after a long, hard winter.

The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.

The companies said that protection plus a good safety record means the vaccine should qualify for emergency use authorization, something the Food and Drug Administration can grant before the final testing is fully complete. In addition to Friday’s FDA submission, they have already started “rolling” applications in Europe and the U.K. and intend to submit similar information soon.

“Our work to deliver a safe and effective vaccine has never been more urgent,” Pfizer CEO Albert Bourla said in a statement.

With the coronavirus surging around the U.S. and the world, the pressure is on for regulators to make a speedy decision.

“Help is on the way,” Dr. Anthony Fauci, the top U.S. infectious disease expert said on the eve of Pfizer’s announcement, adding that it’s too early to abandon masks and other protective measures. “We need to actually double down on the public health measures as we’re waiting for that help to come.”

Friday’s filing would set off a chain of events as the FDA and its independent advisers debate if the shots are ready. If so, still another government group will have to decide how the initial limited supplies are rationed out to anxiously awaiting Americans.

How much vaccine is available and when is a moving target, but initial supplies will be scarce and rationed. Globally, Pfizer has estimated it could have 50 million doses available by year’s end.

About 25 million may become available for U.S. use in December, 30 million in January and 35 million more in February and March, according to information presented to the National Academy of Medicine this week. Recipients will need two doses, three weeks apart.

Not far behind is competitor Moderna Inc.’s COVID-19 vaccine. Its early data suggests the shots are as strong as Pfizer’s, and that company expects to also seek emergency authorization within weeks.

Here’s what happens next:

Making the Data Public

The public’s first chance to see how strong the evidence really is will come in early December at a public meeting of the FDA’s scientific advisers.

So far, what’s known is based only on statements from Pfizer and BioNTech. Of 170 infections detected to date, only eight were among people who’d received the actual vaccine and the rest had gotten a dummy shot. On the safety side, the companies cite results from 38,000 study participants who’ve been tracked for two months after their second dose. That’s a milestone FDA set because historically, vaccine side effects don’t crop up later than that.

“We’ll drill down on these data,” said FDA adviser Dr. Paul Offit of the Children’s Hospital of Philadelphia.

Think of it like science on trial. A few days before the meeting, the FDA will release its own internal analysis. That sets the stage for the advisers’ daylong debate about any signs of safety concerns and how the new vaccine technology works before rendering a verdict.

They’ll recommend not just whether FDA should allow broader use of the vaccine generally but if so, for whom. For example, is there enough proof the vaccine works as well for older, sicker adults as for younger, healthier people?

There’s still no guarantee. “We don’t know what that vote’s going to be,” said former FDA vaccine chief Norman Baylor.

Emergency Use Isn’t the Same as Full Approval

If there’s an emergency green light, “that vaccine is still deemed investigational. It’s not approved yet,” Dr. Marion Gruber, chief of FDA’s vaccine office, told the National Academy of Medicine this week.

That means anyone offered an emergency vaccination must get a “fact sheet” describing potential benefits and risks before going through with the shot, she said.

There will be a lot of unknowns. For example, the 95% protection rate is based on people who developed symptoms and then were tested for the virus. Can the vaccinated get infected but have no symptoms, able to spread the virus? How long does protection last?

That’s why the 44,000-person study needs to keep running — something difficult considering ethically, participants given dummy shots at some point must be offered real vaccine, complicating the search for answers.

And at least for now, pregnant women won’t qualify because they weren’t studied. Pfizer only recently began testing the vaccine in children as young as 12.

A decision on Pfizer’s vaccine won’t affect other COVID-19 vaccine candidates in the pipeline, which will be judged separately.

Manufacturing

Brewing vaccine is more complex than typical drug manufacturing, yet the millionth dose to roll out of Pfizer’s Kalamazoo, Michigan, factory must be the same purity and potency as every dose before and after.

That means the FDA decision isn’t just based on study data, but on its determination that the vaccine is being made correctly.

The Pfizer-BioNTech vaccine — and Moderna’s shots — are made with brand-new technology. They don’t contain the actual coronavirus. Instead, they’re made with a piece of genetic code for the “spike” protein that studs the virus.

That messenger RNA, or mRNA, instructs the body to make some harmless spike protein, training immune cells to recognize it if the real virus eventually comes along.

Getting Into People’s Arms

Another government group — advisers to the Centers for Disease Control and Prevention — decides who is first in line for scarce doses. Health and Human Services Secretary Alex Azar said he hopes that decision can be made at the same time as FDA’s.

The Trump administration’s Operation Warp Speed has worked with states to line up how many doses they’d need to cover the populations offered vaccine first.

Pfizer will ship those supplies as ordered by the states — only after FDA gives the OK.

Company projections of how much it will ship each month are just predictions, Baylor warned.

“It’s not like a pizza,” he said. Manufacturing is so complex that “you don’t necessarily end up with what you thought.”

RELATED TOPICS:

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Fresno Police Find Two Narcotics Labs, Firearms in Southeast Home

DON'T MISS

Fresno County Garnet Fire Grows to More Than 9,000 Acres in Sierra National Forest

DON'T MISS

Three Dead in Minneapolis Shooting, Including Shooter, Justice Department Official Says

DON'T MISS

TikTok Owner ByteDance Sets Valuation at Over $330 Billion as Revenue Grows, Sources Say

DON'T MISS

Fresno County Fatal Collision Under Investigation Near Kerman

DON'T MISS

Israel’s Gaza Campaign Is Making It a Pariah State

DON'T MISS

Trump Administration Plans to Take Control of Washington Union Station

DON'T MISS

Israeli Tanks Close in on Gaza City, Trump to Chair Meeting

DON'T MISS

Trump Says Soros and His Son Should Be Charged With RICO

DON'T MISS

Wall Street Opens Muted in Countdown to Nvidia Earnings

UP NEXT

Trump Administration Plans to Take Control of Washington Union Station

UP NEXT

Trump Says Soros and His Son Should Be Charged With RICO

UP NEXT

Zohran Mamdani, Rapper Turned NYC Mayoral Frontrunner, Embraces Diverse Roots

UP NEXT

Trump Administration Asks US Supreme Court to Halt Foreign Aid Payments

UP NEXT

Poll: Californians Overwhelmingly Reject Trump’s Immigration Policies

UP NEXT

Texas GOP Congressional Candidate Burns Quran With Flamethrower

UP NEXT

California High-Speed Rail Project Hit With New $175 Million Cut

UP NEXT

Poll: Katie Porter Holds Early Edge in California Governor’s Race

UP NEXT

Just 38% of Americans Support Trump’s Use of Troops to Police DC, Reuters/Ipsos Poll Finds

UP NEXT

US to Seek Death Penalty in Washington D.C. Homicide Cases, Trump Says

TikTok Owner ByteDance Sets Valuation at Over $330 Billion as Revenue Grows, Sources Say

1 hour ago

Fresno County Fatal Collision Under Investigation Near Kerman

1 hour ago

Israel’s Gaza Campaign Is Making It a Pariah State

2 hours ago

Trump Administration Plans to Take Control of Washington Union Station

2 hours ago

Israeli Tanks Close in on Gaza City, Trump to Chair Meeting

2 hours ago

Trump Says Soros and His Son Should Be Charged With RICO

2 hours ago

Wall Street Opens Muted in Countdown to Nvidia Earnings

2 hours ago

Zohran Mamdani, Rapper Turned NYC Mayoral Frontrunner, Embraces Diverse Roots

2 hours ago

California Searchers Pull Off High-Altitude Rescue of Missing Hiker

16 hours ago

Judge Grants Fresno Temporary Win in Federal Grant DEI Dispute

17 hours ago

Fresno Police Find Two Narcotics Labs, Firearms in Southeast Home

Fresno police discovered two separate narcotics labs, multiple firearms, and fully functioning slot machines during a probation compliance c...

7 minutes ago

Fresno police discovered two narcotics labs, multiple firearms, and operating slot machines during a probation check, leading to three arrests. (Fresno PD)
7 minutes ago

Fresno Police Find Two Narcotics Labs, Firearms in Southeast Home

The Garnet Fire in Fresno County’s Sierra National Forest has burned 9,170 acres with no containment as crews focus on protecting PG&E infrastructure near Balch Camp, the U.S. Forest Service said Wednesday, August 27, 2025. (U.S. Forest Service)
40 minutes ago

Fresno County Garnet Fire Grows to More Than 9,000 Acres in Sierra National Forest

Photo of caution tape
1 hour ago

Three Dead in Minneapolis Shooting, Including Shooter, Justice Department Official Says

The ByteDance logo is seen at the company's office building in Shanghai, China July 4, 2023. (Reuters File)
1 hour ago

TikTok Owner ByteDance Sets Valuation at Over $330 Billion as Revenue Grows, Sources Say

1 hour ago

Fresno County Fatal Collision Under Investigation Near Kerman

Palestinian Child Carrying Water Amid Gaza City Rubble
2 hours ago

Israel’s Gaza Campaign Is Making It a Pariah State

U.S. National Guard members patrol inside Union Station, after U.S. President Donald Trump deployed National Guard and ordered an increased presence of federal law enforcement to assist in crime prevention, in Washington, DC, U.S., August 21, 2025. (Reuters File)
2 hours ago

Trump Administration Plans to Take Control of Washington Union Station

An Israeli tank manouvres at the Israel-Gaza border, as seen from Israel, August 26, 2025. (Reuters File)
2 hours ago

Israeli Tanks Close in on Gaza City, Trump to Chair Meeting

Search

Help continue the work that gets you the news that matters most.

Send this to a friend